| Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
|---|
| 04/17/2003 | WO2003030811A2 Use of ganoderic acids as cosmetic agents |
| 04/17/2003 | WO2003030616A2 21132, a human g-protein coupled receptor family member and uses therefor |
| 04/17/2003 | WO2003015767A3 Use of tectorigenin for the production of cosmetic or dermatological preparations for the prophylaxis and treatment of inflammatory skin conditions and/or for skin protection of determinate sensitive and dry skin |
| 04/17/2003 | WO2003008457A3 Polysaccharidic esters of retinoic acid |
| 04/17/2003 | WO2003007922A3 Pharmaceutical formulation containing an ltb4 antagonist |
| 04/17/2003 | WO2003007875A3 Compounds with analgesic, antipyretic and/or anti-inflammatory activity |
| 04/17/2003 | WO2003002088A3 Use of an oil of the gourd family for inhibiting 5$g(a)-reductase activity |
| 04/17/2003 | WO2002098852A3 Novel benzothienyl or indole derivatives, and use thereof as inhibitors of prenyl transferase proteins |
| 04/17/2003 | WO2002083700A3 Hypersulfated disaccharides and methods of using the same for the treatment of inflammations |
| 04/17/2003 | WO2002078728A3 Peptides for the treatment of wound contracture |
| 04/17/2003 | WO2002076486A3 Histidine-rich glycoprotein |
| 04/17/2003 | WO2002070706A3 Interleukin-8 homologous polypeptides and therapeutic uses thereof |
| 04/17/2003 | WO2002050289A9 Methods for the production of multimeric proteins, and related compositions |
| 04/17/2003 | WO2002047704A9 Herbal pharmaceutical compositions for treating immunological disorders |
| 04/17/2003 | WO2002032865A1 Novel neurokinin antagonists, method for the production thereof and pharmaceutical compositions containing said compounds |
| 04/17/2003 | WO2002032445A3 Inhibition of the interaction between oxidized proteins and cd36 or the active mechanism thereof |
| 04/17/2003 | WO2002032415A3 Process of making and method of use of tetrahydrocurcuminoids to regulate physiological and pathological events in the skin and mucosa cells |
| 04/17/2003 | WO2002029036A3 Lipid metabolism enzymes |
| 04/17/2003 | WO2002024891A3 B7-like molecules and uses thereof |
| 04/17/2003 | WO2002020619A9 HUMAN ANTIBODIES AGAINST PSEUDOMONAS AERUGINOSA LPS DERIVED FROM TRANSGENIC XENOMOUSE$m(3) |
| 04/17/2003 | WO2002018575A3 Genes expressed in the cell cycle |
| 04/17/2003 | WO2002018445A3 Co-crystal structure of monoclonal antibody 5c8 and cd154, and use thereof in drug design |
| 04/17/2003 | WO2000002548A3 Inhibitors of proteasomal activity for stimulating bone and hair growth |
| 04/17/2003 | WO1999064401A3 Imidazolyl derivatives and their use as somatostatin receptor ligands |
| 04/17/2003 | US20030073857 26,27-Homologated-20-epi-2-alkyl-19-nor-vitamin D compounds |
| 04/17/2003 | US20030073845 Sulfonyl aryl hydroxamates and their use as matrix metalloprotease inhibitors |
| 04/17/2003 | US20030073827 Flea head, nerve cord, hindgut and malpighian tubule nucleic acid molecules, proteins and uses thereof |
| 04/17/2003 | US20030073732 Antiinflammatory agents |
| 04/17/2003 | US20030073723 Antiinflammatory agents; rheumatic diseases; antiallergens |
| 04/17/2003 | US20030073720 Tryptase inhibitors |
| 04/17/2003 | US20030073719 Chiral salt resolution |
| 04/17/2003 | US20030073718 Enzyme inhibitors; cardiovascular disorders; antiinflammatory agents; autoimmune disease |
| 04/17/2003 | US20030073712 Antiinflamamtory agents; antiischemic agents |
| 04/17/2003 | US20030073704 Analgesics; antidiabetic agents; antiinflamamtory agents |
| 04/17/2003 | US20030073699 Compounds and methods to treat cardiac failure and other disorders |
| 04/17/2003 | US20030073698 Nitrogen-based camptothecin derivatives |
| 04/17/2003 | US20030073692 Anticancer agents; viricides; Alzheimer's diseases |
| 04/17/2003 | US20030073685 Nitric oxide synthase inhibitor; antiinflammatory agents |
| 04/17/2003 | US20030073682 Novel substituted aryl hydroxamic acids as metalloproteinase inhibitors |
| 04/17/2003 | US20030073669 N-heterocyclic derivatives as NOS inhibitors |
| 04/17/2003 | US20030073616 Hair growth; controlling apolecia |
| 04/17/2003 | US20030073167 DNA encoding SNORF36 receptors |
| 04/17/2003 | US20030072824 Having anti-oxidant, gastric mucosa injury inhibiting, aldose reductase inhibiting, blood glucose level elevation inhibiting action, platelet agglutination accelerating action, alcohol absorption inhibition, anti-inflammation properties |
| 04/17/2003 | US20030072820 For topical use on the skin, mucous membrane and/or hair, nails |
| 04/17/2003 | US20030072816 Agents improving skin barrier function |
| 04/17/2003 | US20030072777 Combinatorial anti-acne compositions |
| 04/17/2003 | US20030072752 Two novel genes from psoriatic epidermis: psoriastatin type i and psoriastatin type ii |
| 04/17/2003 | US20030072732 Comprises association between elastase inhibitor compound of the N-acylaminoamide family and at least one antiinflammatory compound; for improving skin ageing and/or photoageing signs by slowing down connective tissue alterations |
| 04/17/2003 | US20030072726 Phenolic compounds from natural biological materials such as plant material |
| 04/17/2003 | DE4345439C2 Malotilate for accelerating wound healing of damaged tissues |
| 04/17/2003 | CA2464662A1 Modulation of the expression of genes dependent on stat-1 |
| 04/17/2003 | CA2463496A1 Method of obtaining an extract of ginger |
| 04/17/2003 | CA2463364A1 2-amino-6-(2,4,5-substituted-phenyl)-pyridines for use as nitric oxide synthase inhibitors |
| 04/17/2003 | CA2463339A1 Controlled release drug delivery composition comprising polycationic polymer and negatively charged pharmacologically active compound |
| 04/17/2003 | CA2463198A1 Pyrrolidinone derivatives |
| 04/17/2003 | CA2462950A1 3-[4-(substituted heterocyclyl)-pyrrol-2-ylmethylidene]-2-indolinone derivatives as kinase inhibitors |
| 04/17/2003 | CA2462892A1 Human 3 relaxin |
| 04/17/2003 | CA2462881A1 Intraorally disintegrating valdecoxib compositions prepared by spray drying process |
| 04/17/2003 | CA2462862A1 3,4-di-substituted maleimide compounds as cxc-chemokine receptor antagonists |
| 04/17/2003 | CA2462809A1 Flavonoid compounds and their pharmaceutical uses |
| 04/17/2003 | CA2462579A1 Use of tazarotene for preparing a nail varnish for treating and/or preventing psoriasis and nail varnish containing same |
| 04/17/2003 | CA2462291A1 Methods and compositions for treating dermal lesions |
| 04/17/2003 | CA2461960A1 Combinatorial anti-acne compositions |
| 04/17/2003 | CA2461435A1 Angiopoietin-2 specific binding agents |
| 04/17/2003 | CA2461064A1 Inhibition of stat-1 |
| 04/17/2003 | CA2460476A1 Protein modification and maintenance molecules |
| 04/17/2003 | CA2458464A1 Monoclonal and cdr-grafted antibodies specific for human kdr |
| 04/17/2003 | CA2458453A1 Acylsulfonamides as inhibitors of steroid sulfatase |
| 04/16/2003 | EP1302533A1 Novel method of inducing the differentiation of embryonic stem cells into ectodermal cells and use thereof |
| 04/16/2003 | EP1302460A1 Indolecarboxylic compounds and their use as pharmaceutical compounds |
| 04/16/2003 | EP1302189A1 Cosmetic compositions for reducing and method of using the same |
| 04/16/2003 | EP1302113A1 Physiologically functional foods or cosmetics containing sphingoglycolipids and processes for their production |
| 04/16/2003 | EP1301797A2 Antimicrobial agent |
| 04/16/2003 | EP1301598A2 Cell cycle proteins and mitosis-associated molecules |
| 04/16/2003 | EP1301539A2 Antigen-binding fragments specific for dendritic cells, compositions and methods of use thereof antigens recognized thereby and cells obtained thereby |
| 04/16/2003 | EP1301535A2 G-protein coupled receptors |
| 04/16/2003 | EP1301524A1 B7-like polynucleotides, polypeptides, and antibodies |
| 04/16/2003 | EP1301522A1 Novel compounds and methods |
| 04/16/2003 | EP1301514A1 Aryl and heteroaryl diazabicycloalkanes, their preparation and use |
| 04/16/2003 | EP1301507A2 Mannich base prodrugs of 3 - (pyrrol-2-ylmethylidene)-2-indolinone derivatives and their use as modulators of protein kinases |
| 04/16/2003 | EP1301500A1 Nitrosated and nitrosylated taxanes, compositions and methods of use |
| 04/16/2003 | EP1301497A1 Colchinol derivatives as vascular damaging agents |
| 04/16/2003 | EP1301495A2 Inhibitors of copper-containing amine oxidases |
| 04/16/2003 | EP1301490A2 5-substituted 2-aryl-4-pyrimidinones |
| 04/16/2003 | EP1301484A2 Capsaicin receptor ligands |
| 04/16/2003 | EP1301472A2 Oxygenated esters of 4-iodo phenylamino benzhydroxamic acids |
| 04/16/2003 | EP1301460A1 Method for preparing a fatty substance ester and use thereof in pharmaceutics, cosmetics or food industry |
| 04/16/2003 | EP1301207A2 Compositions for treating bacterial infections, containing an oxazolidinone compound, sulbactam and and ampicillin |
| 04/16/2003 | EP1301203A1 Vaccine comprising active agent immunogenic acyl glyceryl phosphatidylinositol manno-oligosaccharide |
| 04/16/2003 | EP1301189A2 USE OF 2-METHYLENE-19-NOR-20(S)-1$g(a),25-DIHYDROXYVITAMIN D 3? TO INCREASE BONE STRENGTH |
| 04/16/2003 | EP1301171A1 Use of extracted soluble protein fractions |
| 04/16/2003 | EP1181047B1 Composition comprising alkaline sphingomyelinase for use as a dietetic preparation, food supplement or pharmaceutical product |
| 04/16/2003 | EP1054691B1 Anti-enzyme antibodies for the treatment of the skin |
| 04/16/2003 | EP0977565B1 Pharmaceutical composition comprising a tricyclic compound with enhanced stability, absorbability and low irritation potential |
| 04/16/2003 | EP0961609B1 Methods for improving the health of hair and scalp |
| 04/16/2003 | EP0869945B1 Catechol diethers derivatives useful as pharmaceutical agents |
| 04/16/2003 | EP0861032B1 Aquatic animal treatment method and composition containing cajeput oil |
| 04/16/2003 | EP0824544B1 Peptidyl compounds which inhibit metalloproteinase and tnf liberation and their therapeutic use |
| 04/16/2003 | EP0801554B1 Formulations and methods for reducing skin irritation |
| 04/16/2003 | EP0800382B1 Use of compositions with benzoyl peroxide, glycolic acid and zinc for the treatment of dermatological disorders |